CARMELL CORP (CTCX)

Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community

Carmell provides its revolutionary regenerative skincare through the first of its kind partnership with Ladies Playbook, an exclusive community dedicated...

CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q2 2024

Carmell Therapeutics just reported results for the second quarter of 2024.

CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Carmell Therapeutics (NASDAQ:CTCX) just reported results for the second quarter...

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman....

CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023

Carmell Therapeutics just reported results for the fourth quarter of 2023.

CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q1 2024

Carmell Therapeutics just reported results for the first quarter of 2024.

Carmell Announces Successful Closing of $3.0 Million Private Placement

PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”,...

Carmell Announces $3.0 Million Private Placement

PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”,...

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”,...

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

Carmell today announced the execution of a definitive agreement to sell its wholly owned subsidiary Axolotl Biologix...

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

Carmell to host an Investor Webinar titled “Unveiling the Secretome: On the Eve of Product Launch”...

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

Carmell announced GLEE product ready for commercial launch in Mar 2024 plus 9 products anticipated to launch by mid 2024....

Carmell CEO buys shares worth over $15.5k - filing (NASDAQ:CTCX)

Carmell Corp (NASDAQ:CTCX) CEO Rajiv Shukla disclosed in an SEC filing on Tuesday after the bell a purchase of 6,000 shares of the company worth over...

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a human biomaterials company (“Carmell”), today announced the addition...

Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine

/PRNewswire/ -- Moonshot is excited to announce that its incubator client, Axolotl Biologix, based in its NACET Flagstaff, Arizona campus, has finalized a...

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the...

Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

MNK, AAOI and TUP are among pre market gainers (NASDAQ:CTCX)

Carmell Therapeutics  (CTCX) +54%. Lipocine  (LPCN) +36% meets primary endpoint in Patients with cirrhosis.Celestica (CLS) +30% Q2 earnings call releaseUltralife Corporation (ULBI) +30%...